MediciNova to Sell Common Shares, Preferred Shares to Kissei

MediciNova Inc. (MNOV) plans to sell to Kissei Pharmaceutical Co. 800,000 common shares for $2 million and 220,000 preferred shares for $5.5 million.

The share sale was disclosed in filings today with Japan’s finance ministry.

To contact the editor responsible for this story: Taku Kato at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.